More men at risk for prostate cancer as a result of less regular screening
the ONA take:
A recent research study examined the potential benefits and potential downsides to the US Preventive Services Task Force (USPSTF) recommendation against regular prostate-specific antigen (PSA) screening for prostate cancer.
Researchers, led by Daniel A. Barocas, MD, MPH, of the Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, examined the number and distribution of new prostate cancer diagnoses in the United States.
Incident cancers diagnosed from January 2010 through December 2012 were included. The number of new prostate cancer cases diagnosed before and after the USPSTF recommendation were compared against a similar record of colon cancer findings.
The investigators found a drop in the number of prostate cancer diagnoses, a greater than 12% decline, following the USPSTF's PSA screening recommendation.
Prostate cancer diagnoses at all risk levels fell, though new diagnoses of nonlocalized disease did not change. Monthly colon cancer diagnoses remained steady before and after the USPSTF recommendation.
One year after the USPSTF recommendation, diagnoses of new low risk cancers dropped by nearly 38%, which does address the USPSTF intent to reduce overdiagnosis, but the researchers have concerns that the reduction in high- and immediate-risk disease diagnoses could lower chances for early detection and treatment.
pThe team feels that additional research into screening models to maximize early detection for higher risk cancers while keeping overdiagnosis and overtreatment numbers low would be beneficial.
Data from this study were published in The Journal of Urology.
A recent study examined the potential benefits and potential downsides to the USPSTF recommendation against regular PSA screening.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|